Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Neoplasms
×
ribociclib
×
Breast
×
Clear all
Filters
3
NCT05768139
2026-03-02
PIKALO-1
Eli Lilly and Company
Phase 1/2
Recruiting
720 enrolled
NCT04964934
2026-01-16
SERENA-6
AstraZeneca
Phase 3
Active not recruiting
315 enrolled
NCT02422615
2023-11-30
MONALEESA-3
Novartis
Phase 3
Completed
726 enrolled
17 charts
1 FDA
NCT02187783
2019-07-18
SIGNATURE
Novartis
Phase 2
Completed
106 enrolled
16 charts